H epatic synthesis of bile acids and their subsequent elimination in faeces constitute the main physiological way for the removal of body cholesterol. Thus they contribute greatly to the maintenance of cholesterol homeostasis. 1 The regulation of hepatic bile acid biosynthesis, which has been extensively studied, has highlighted the crucial role played by the cholesterol-7a-hydroxylase (CYP7A1) in cholesterol balance. 2 In rodents, this rate limiting enzymewhich promotes the conversion of cholesterol into bile acids 2 -is upregulated by sterols through an LXRa dependent pathway. [3] [4] [5] Conversely, the CYP7A1 gene is downregulated by bile acids through a feedback loop involving SHP dependent and independent pathways. [6] [7] [8] [9] [10] [11] In humans, only bile acid mediated repression is present. [12] [13] [14] Paradoxically, the regulation of intestinal bile acid reclamation remains poorly known, though this step is crucial for maintaining a constant bile acid pool. Indeed, in healthy humans and rodents, more than 90% of bile acids are reabsorbed by the small intestine and return to the liver to be secreted again into the bile. [15] [16] [17] This efficient bile acid recycling mainly takes place in the ileum through an active process involving a 48 kDa integral brush border membrane glycoprotein termed apical sodium dependent bile acid transporter (ASBT), or ileal-bile acid transporter (I-BAT). [18] [19] [20] There is compelling evidence that ASBT is essential for efficient bile acid uptake by the ileum. First, the primary bile acid malabsorption syndrome-caused by inherited mutations in human ASBT gene-is associated with a defective enterohepatic bile acid circulation, congenital steatorrhoea, and a reduced blood cholesterol concentration. 21 22 Second, the targeted deletion of the ASBT gene in mice leads to a dramatic rise in faecal bile acid excretion and a decrease both in bile acid pool size and hepatic cholesterol ester levels. 23 Third, ASBT inhibitors strongly enhance faecal bile acid outputs, reduce plasma cholesterol level and atherosclerosis risk in various species. [24] [25] [26] [27] [28] This important homeostatic gene appears be tightly downregulated by bile acids in both mice and human. 29 30 By contrast, although the basal expression of the ASBT gene is highly dependent on the transcription factor HNF-1a 31 32 -a major player in cholesterol homeostasis 31 the direct impact of cholesterol on the ASBT gene remains controversial. Indeed, the mild rise in ileal ASBT protein levels found in rabbits subjected to cholesterol feeding was not reproduced in rats. 33 Moreover, experiments done in mice are conflicting as cholesterol mediated upregulation and downregulation of the ASBT gene have both been reported. 34 35 However, the fact that bile acid influx into Caco-2 cells is depressed by oxysterols strongly suggests that ASBT is a sterol target gene, at least in vitro. 36 Abbreviations: ASBT, apical sodium dependent bile acid transporter; CAT, chloramphenicol acetyltransferase; CYP7A1, cholesterol 7a-hydroxylase; EMSA, electrophoretic mobility shift assay; FCS, fetal calf serum; FXR, farnesoid-X receptor; HMG-CoA reductase, hydroxymethylglutaryl-coenzyme A reductase; HNF, hepatocyte nuclear factor; HNFE, HNF-1a responsive element; 25(OH)CS, 25-hydroxycholesterol; LDL, low density lipoprotein; LXR, liver X-receptor; NCTC, National Collection of Type Cultures; NTCP, Na + -taurocholate co-transporting polypeptide; OATP, organic anion transport protein; PGC-1, PPAR c co-activator 1; PPAR, peroxisome proliferator activated receptor; SHP, small heterodimer partner; SRE, sterol responsive element; SREBP, sterol regulatory element binding protein; TCA, taurocholic acid By using a combination of physiological, cellular, and molecular approaches we show in this report that ASBT gene expression is repressed by cholesterol in both mice and human enterocyte-like Caco-2 cells. This effect is direct and leads to a decrease in the cellular uptake of bile acids. Analysis of both human and mice ASBT promoters strongly suggests that this cholesterol mediated downregulation takes place at a transcriptional level through an original regulatory pathway involving a partnership between the transcription factors SREBP-2 and HNF-1a.
METHODS

Animals and experimental treatments
French guidelines for the use and care of laboratory animals were followed. Protocols were approved by the ethics committee of the University of Burgundy. Eight week old male C57BL6/J mice were purchased from Charles River (France). In a first set of experiments, the impact of body cholesterol status on ASBT gene expression was explored in mice. To induce a cholesterol overload, mice were fed ad libitum on a 2% cholesterol enriched diet for 14 days, while the control animals were subjected to a standard laboratory chow containing 0.02% cholesterol (UAR A04, Saint Genest, France). Body cholesterol depletion was induced by force feeding with the HMG-CoA reductase inhibitor simvastatin (100 mg/kg/d of simvastatin) for four days. Controls received the vehicle alone (1% carboxymethyl cellulose) by the same route, as described previously. 37 The second set of experiments was carried out to evaluate impact of cholesterol on intestinal bile acid reclamation. To assess faecal bile acid elimination accurately, mice were placed in individual metabolic cages and were fed either a low or a high cholesterol diet (0.02% or 2%, respectively) for 14 days. Bile acid content of the faeces was determined by gas chromatography. 38 At the end of this period, an in situ isolated ileal loop was formed to evaluate the level of intestinal bile acid uptake. 24 39 In brief, a rapid laparotomy was done on isofluorane anaesthetised animals and a 5 cm segment of the terminal ileum was isolated in situ between two catheters. The ileal segment was gently rinsed with a prewarmed phosphate buffered saline (PBS) (0.9% NaCl, 0.01% sodium phosphate, 37˚C) before being infused with 200 ml of [ 3 H]-taurocholic acid (TCA) (3 mM, 1.19 mCi/ mmol). At the end of the incubation period, the ileal loop was rapidly removed and rinsed with 10 ml of cold PBS (4˚C) to terminate cellular bile acid uptake.
[ 3 H]-Taurocholic acid uptake by intestinal cells Mucosa from in situ isolated intestinal loops was lysed in 0.2 N NaOH (for four hours at 37˚) before the determination of bile acid uptake. For in vitro experiments, 21day postconfluent human enterocyte-like Caco-2 cells were cultured in a sterol enriched (10 mg/ml cholesterol, 1 mg/ml 25-hydroxycholesterol) Dulbecco modified Eagle's medium (DMEM) for 48 hours. The choice of the 10:1 ratio between cholesterol and 25-hydroxycholesterol was based on previous work from Brown and Goldstein's laboratory. 40 Control cultures received vehicle alone (11 ml ethanol). Cells were washed three times with prewarmed PBS (37˚C), then incubated at 37˚C for 20 (Roche) and normalised to b-galactosidase activity. pCMV-bgalactosidase expression vector was introduced in equal amount in each transfection mix, as described below.
Electrophoretic mobility shift assay (EMSA) SREBP-2 and HNF-1a were synthesised using the TNT rabbit reticulocyte lysate coupled to an in vitro transcription/ translation system (Promega). The doubled strand oligonucleotide probes were obtained by hybridising single strand complementary oligonucleotides (Eurogentec). The sequences used are listed in table 1. The dimers were labelled with [c- 32 P]ATP using the T4 polynucleotide kinase (Invitrogen). For the gel mobility shift assays, HNF-1a or SREBP-2 proteins (1 and 2 ml, respectively), or both, were incubated on ice for 15 minutes with 10 ng of [c- 32 P] end labelled dimerised oligonucleotides, and 0.5 mg of sonicated salmon sperm DNA in 20 mM HEPES (pH 7.8), 120 mM KCl, 0.4% nonidet P-40, 12% glycerol, and 2 mM dithiothreitol. Equivalent gel loading was ensured by addition of processed empty vector. For the supershift experiment, 1 ml of anti-SREBP-2 antibody (N-19: sc-8151, Santa Cruz Biotechnology), or 1 ml of anti-HNF-1 antibody (H205: sc-8986, Santa Cruz Biotechnology) was added to the reaction mixes, then incubated on ice for 30 minutes. Reactions were analysed by electrophoresis through a 4% polyacrylamide gel in 0.5 M TBE (90 mM Tris, 90 mM boric acid, 2 mM EDTA). Gels were dried, then subjected to autoradiography at 270˚C.
Cell culture and transfection assays
The human Caco-2 cells were maintained in DMEM supplemented with 4 mM glutamine, 1% non-essential amino acids, 100 units/ml penicillin, 100 mg/ml streptomycin, and 10% fetal calf serum (FCS). For the transactivation assays, cells were plated in six-well plates at 40-50% confluency, then transfected by the calcium phosphate precipitation method. The transfection mixes contained 4 mg of mouse or human ASBT promoter reporter plasmids, 500 ng of pCMV-bgalactosidase expression vector, 50 to 250 ng SREBP-2 expression vector (gift from Dr TF Osborne, University of California, Irvine, California, USA), and/or 100 ng HNF-1a expression vector (gift from Dr W Wahli, University of Lausanne, Switzerland) according to the experiment. For SREBP-2 experiments, 10 mg/ml cholesterol and 1 mg/ml 25-hydroxycholesterol were added 12 hours after the transfection to inhibit endogenous SREBP maturation. 40 41 For the cholesterol sensitivity assessment, the culture medium was changed 12 hours after transfection with an experimental medium containing 10% lipoproteinfree FCS plus 10 mg/ml of simvastatin (sterol2 condition) or 10 mg/ml cholesterol plus 1 mg/ml 25-hydroxycholesterol (sterol+ condition) for 24 hours. Control cultures received the vehicle alone (11 ml ethanol). Cellular extracts were assayed for CAT and b-galactosidase activities. For RNA isolation experiments, Caco-2 cells were plated onto 60 mm diameter dishes at 60% confluency and transfected using JetPEI (PolyPlus tranfection) with 2 mg SREBP-2 or 2 mg HNF-1a expression vectors, or both; or they were differentiated for 21 days and then cultured in sterol enriched medium (cholesterol and 25-hydroxycholesterol for 48 hours, 10:1 ratio) or in sterol depleted medium (simvastatin 5 mg/ml for 48 hours).
Organ culture of ileal explants Ileal explants from mice were obtained and cultured according to a previously published procedure. 42 Explants were cultured in a medium (DMEM, 10% NCTC 135, 2 mM L-glutamine, 2.5 mg/ml fungizone, 100 mg/ml gentamicin) supplemented with 10% lipoprotein-free FCS in the presence of 10 mg/ml cholesterol and 1 mg/ml 25-hydroxycholesterol for 18 hours. Control cultures were treated with vehicle alone (11 ml ethanol).
Northern blotting
Total RNA from mouse ileal explants and Caco-2 cells was extracted with the RNeasy kit (Qiagen) and Trizol reagent (Invitrogen), respectively; 20 mg of RNAs were electrophoresed on a 1% agarose gel, then transferred onto Genescreen membranes (PerkinElmer Life Sciences). ASBT cDNA probe, and 18S rRNA oligonucleotide were [a-
32 P]dCTP and [c- 32 P]ATP labelled, respectively. Blot size was quantified using a GS-800 calibrated densitometer (Biorad). Real time quantitative PCR cDNA was produced from 1 mg total RNA by reverse transcription (Superscript II reverse transcriptase, Invitrogen). Real time PCR was undertaken using the ICycler IQ detection system (Biorad) with 50 ng cDNA, and qPCR MasterMix Plus SYBR (Eurogentec). The primers used for mRNA quantification are listed in the table 1. Quantification of data was done by the comparative DDCt method. 43 Western blotting Twenty micrograms of total proteins extracted from the ileal mucosa were prepared in ice cold buffer (0.154 M KCl, 0.01 M phosphate buffer, pH 7.4), separated on 10% SDS-PAGE, then blotted onto a Polyscreen membrane (PerkinElmer Life Sciences). Polyclonal ASBT antibodies were generated by Eurogentec. Anti-rabbit peroxidase conjugated secondary antibodies were purchased from Sigma. Antibodies were diluted at 1:5000, and 1:20 000, respectively. Anti-b-actin antibodies (Sigma) was used as controls (1:20 000 dilution). Detection was undertaken using the ECL blotting kit (PerkinElmer Life Sciences). Blot size was quantified using GS-800 calibrated densitometer (Biorad).
Statistical analysis
The results are expressed as means (SEM). The significance of the differences between groups was determined by Student's t test. 
RESULTS
ASBT expression is downregulated by cholesterol
The impact of body cholesterol levels on ASBT gene expression was assessed in mice fed either a 2% cholesterol diet or force fed the hypocholesterolaemic drug simvastatin. Chronic dietary cholesterol overload significantly decreased ASBT mRNA and the protein levels in ileal mucosa ( fig 1A) . Conversely, simvastatin mediated cholesterol depletion led to a rise in ASBT mRNA and protein level (fig 1B) . In the mouse, cholesterol mediated stimulation of bile acid synthesis 3-5 raises the possibility that repression of ASBT gene in ileal mucosa is an indirect event secondary to its inhibition by bile acids. 29 30 To address this question, mouse ileal explants were cultured in a sterol enriched medium. As shown in fig 1C, a 40% fall in ASBT mRNA levels occurred in the presence of sterols. A similar regulation was also found in human Caco-2 cells in which sterols decreased ASBT gene expression in a dose dependent manner ( fig 1D) . As reported in the mouse, cholesterol depletion induced by simvastatin reduced the ASBT mRNA levels in Caco2 cells ( fig 1E) . Altogether these data show that mouse and human ASBT genes are sterol targets. construct and 100 ng of HNF-1a expression vector, and cultured during 24 hours with the indicated amounts of cholesterol and 25-hydroxycholesterol (25(OH)CS). CAT activity was normalised to b-galactosidase activity (n = 3). Values are means with SEM; *p,0.05, **p,0.01, ***p,0.001 (n = 3). ASBT, apical sodium dependent bile acid transporter; CAT, chloramphenicol acetyltransferase; HNF, hepatocyte nuclear factor; SREBP, sterol regulatory element binding protein.
Cholesterol decreases bile acid uptake in intestinal cells
To determine whether the cholesterol mediated changes in ASBT gene expression affect the influx of bile acid into intestinal cells, an emulsion containing 3 mM [ 3 H]-TCA was infused into an in situ isolated ileal loop from mice fed a standard chow or a cholesterol enriched diet. As this method-which keeps the enteric blood circulation intactis highly sensitive to the incubation time, a preliminary experiment was undertaken to determine the time needed for optimal [ 3 H]-TCA uptake. Because the highest uptake of TCA occurred at one minute (fig 2A, insert) , this time was used for subsequent experiments. As expected, the cholesterol mediated decrease in ASBT gene expression was associated with a significant fall in ileal bile acid uptake (fig 2A) . In line with this result, the faecal bile acid output was increased in mice subjected to chronic cholesterol feeding ( fig 2B) . In differentiated Caco-2 cells, an inverse correlation between [ 3 H]-TCA uptake capacity and sterol concentration was found ( fig 2C) . Again, these functional changes paralleled the ASBT expression level quite well ( fig 1A) .
Mouse and human ASBT promoters are SREBP-2 sensitive
The transcriptional origin of this regulation of the ASBT gene was suggested by transfection assays. Indeed, sterols induced a significant fall in the activity of CAT reporter gene driven by the mouse or human ASBT promoters ( fig 3A) . Conversely, sterol depletion mediated by the addition of simvastatin (sterol2) increased the transactivation of the reporter gene ( fig 3A) . Cholesterol is known to regulate the expression of target genes involved in its own metabolism through the activation of the sterol responsive element binding protein-2 (SREBP-2). Cellular depletion of cholesterol triggers a proteolytic cleavage and the nuclear translocation of mature SREBP-2, which transactivates target genes by binding to specific SREBP responsive elements (SRE). 44 45 To determine whether sterol mediated control of ASBT gene expression takes place through this pathway, mouse ASBT 21042/+118 promoter was co-transfected with an expression vector encoding for the active SREBP-2 peptide. As expected, the activity of the reporter gene was increased in the presence of SREBP-2. Moreover, this effect was dose dependent (fig 3B) . The progressive 59 deletions of mouse ASBT promoter showed that the proximal mASBT 2108/+26 sequence was sufficient to confer SREBP-2 responsiveness (fig 3C) . Interestingly, human ASBT promoter showed a similar pattern of regulation ( fig 3D) .
ASBT responsiveness to SREBP-2 is HNFE dependent
Paradoxically, bioinformatic analysis (MatInspector, www.genomatix.de) and EMSA failed to reveal the existence of an SRE sequence in the proximal sequence of ASBT promoter. By contrast, the nucleotide sequence alignments of mouse and human ASBT promoters showed that two responsive elements for HNF-1a (HNFE) are highly conserved ( fig 4A) . As HNF-1a is a major regulator for ASBT gene expression, 31 32 and as interactions between HNFs and SREBPs are known, 46 47 a putative involvement of these HNFE sequences in cholesterol mediated regulation of the ASBT gene was explored. Both SREBP-2, and HNF-1a transactivated the mASBT 2108/+26 sequence ( fig 4B) . Surprisingly, co-transfection with SREBP-2 and HNF-1a expression vectors together led to a large rise in CAT activity. This synergic action was SREBP-2 specific as it was not reproduced with SREBP-1c ( fig 4B) . In line with these data, only the concomitant transfection of SREBP-2 and HNF-1a was able to produce a significant increase in endogenous ASBT expression in human Caco-2 cells (fig 4C) . Conversely, the transactivation of CAT reporter gene in presence of HNF1a was decreased when SREBP activation was inhibited by the use of the sterol (+) condition ( fig 4D) . Taken together these data strongly suggest that a partnership between SREBP-2 and HNF-1a allows the responsiveness of ASBT promoter to cholesterol. In addition, HNFE sequences seem to play a crucial role in this regulation as SREBP-2 did not directly interact with ASBT promoter. To explore this hypothesis, the involvement of HNFE sequences found in mouse and human ASBT promoters were analysed by 59 sequence deletions or targeted mutagenesis. Deletion of the distal HNFE 289/275 sequence of mouse ASBT promoter decreased the synergic response to SREBP-2 and HNF-1a, the double deletion of HNFE sequences fully abolishing the transactivation (fig 5A) . Similar results were also obtained with human promoter (fig 5B) .
To explore further the role of HNFE sequences in this regulation, the mASBT 250/224 sequence containing the proximal HNFE 239/224 -sharing 100% homology with human ASBT proximal HNFE +308/+323 ( fig 4A) -was cloned upstream of a reporter gene driven by the strong SV40 promoter, then co-transfected together with SREBP-2 and/or HNF-1a expression vectors in Caco-2 cells. As shown fig 5C, this short sequence was sufficient to reproduce the cooperative action of SREBP-2 and HNF-1a fully, demonstrating the involvement of this promoter region containing a canonical HNFE sequence in cholesterol mediated regulation of ASBT gene. The absence of a physical interaction between SREBP-2 and the mASBT 250/224 sequence was further confirmed by EMSA ( fig 5D) . While in vitro translated SREBP-2 was bound to the canonical SRE sequence of the LDL receptor (lanes 2 and 3), no shift was detected with the mASBT 250/224 probe (lane 5). This data show the inability of SREBP-2 to bind the sterol sensitive sequence of mouse ASBT promoter, in contrast to HNF-1a (lanes 6 and 7).
Cholesterol mediated regulation of ASBT gene is not due to a sterol dependent induction of HNF-1a expression The present data clearly show the involvement of HNF-1a in cholesterol mediated regulation of the ASBT gene. To explore whether the transactivation of ASBT promoter by SREBP-2 resulted from an induction of the HNF-1a gene by cholesterol, we subcloned human HNF-1a 2473/+4 promoter upstream of a CAT reporter gene and assessed its responsiveness to sterols or SREBP-2 in Caco-2 cells. In contrast to ASBT promoter, neither sterol+ nor sterol2 conditions (fig 6A) , nor SREBP-2 were able to affect the reporter gene activity significantly when it was driven by HNF-1a promoter ( fig 6B) . In agreement with these in vitro data, no change in HNF-1a mRNA levels was found in mice subjected to a dietary cholesterol overload, or force fed with the hypocholesterolaemic drug simvastatin for four days ( fig 6C) .
DISCUSSION
Adjustment of hepatic synthesis and ileal reclamation of bile acid contribute greatly to the maintenance of cholesterol homeostasis, and therefore to the protection against gallstone formation and cardiovascular diseases. While it is well known that cholesterol directly affects hepatic bile acid synthesis in rodents, 2 3 5 its impact on intestinal uptake and subsequent faecal elimination of bile acids is still unclear. The present data provide the first demonstration that a dietary cholesterol overload leads to a strong downregulation of ASBT expression, associated with a 20% fall in ileal bile acid uptake and a twofold rise in faecal bile acid elimination in the mouse. These changes are in good agreement with previous data obtained in rats treated with pharmacological inhibitors of ASBT. Indeed, the use of the drug 264W94 produces to a twofold increase in faecal bile acid outputs despite a 24% inhibition of bile acid uptake. 24 Thus a moderate decrease in ileal bile acid uptake markedly affects bile acid balance in rodents.
The origin of this regulation remains elusive in vivo, as a cholesterol mediated rise in hepatic bile acid synthesis by itself could account for the decreased ASBT expression. 29 The use of mouse ileal explants shows that ASBT gene can also be directly affected by sterols. Indeed, this ex vivo approach sequence to in vitro translated SREBP-2 or HNF1a proteins. Supershift experiments were carried out by incubating for 15 minutes on ice with SREBP-2 protein (2 ml) or HNF-1a protein (1 ml), indicating [ 32 P]-end labelled probes with or without specific SREBP-2 or HNF-1a antibodies (1 ml). Values are means with SEM; **p,0.01, ***p,0.001 (n = 3). ASBT, apical sodium dependent bile acid transporter; CAT, chloramphenicol acetyltransferase; HNF, hepatocyte nuclear factor; HNFE, HNF-1a responsive element; SREBP, sterol regulatory element binding protein.
allows the study of gene expression independently from exogenous (that is, luminal) and endogenous (blood and nervous) influences. Thus both bile acid and cholesterol downregulate ASBT gene expression in mice fed a cholesterol enriched diet. This concomitant repression might explain the high efficiency of faecal bile acid wasting and hence contribute to the well known resistance of the mouse to diet induced hypercholesterolaemia. 1 13 48 49 As ASBT mRNA levels and bile acid uptake are also inversely correlated with sterol levels in human enterocyte-like Caco-2 cells, it is tempting to speculate that there is a common regulation pattern in the mouse and the human. This assumption, supported by the recent results from Alrefai et al, 36 is reinforced by the fact that both mouse and human ASBT promoters are sterol sensitive ( fig 3A) .
The molecular mechanism whereby this regulation takes place is not fully elucidated. The transcription factor SREBP-2 was a plausible candidate for such a function. Indeed, SREBP-2 is known to regulate several key genes involved in the control of cholesterol homeostasis (for example, LDL receptor, HMG CoA reductase), secondary to a sterol dependent proteolytic activation. 44 45 Moreover, this maturation of SREBP-2 is functional in the ileum of rodents. 50 51 Finally, initial transfection studies using mouse ASBT reporter gene constructs showed that the promoter activity was induced in a dose dependent manner by the active SREBP-2 peptide (fig 3B) . Paradoxically, the CAT activity remains significantly high when SREBP-2 is co-transfected with the mASBT 2108/+26 sequence in which a SREBP responsive element was lacking. This finding strongly suggests that the impact of SREBP-2 on ASBT gene expression is indirect. It is noteworthy the mASBT 2108/+26 sequence contains two binding sites for HNF-1a (GNFE), a nuclear receptor recently highlighted as a major regulator of mouse and human ASBT genes. 31 32 Co-transfections with expression vectors encoding for HNF-1a and active SREBP-2 peptide synergistically transactivated the reporter gene driven by the mASBT 2108/+26 sequence. The functional importance of this cooperation is supported by the fact that only a combination of HNF-1a and SREBP-2 was capable of inducing the endogenous ASBT mRNA levels in enterocytelike Caco-2 cells (fig 4C) . There is compelling evidence to support the crucial role exerted by HNFE sites in this regulation. First, in a heterologous promoter context, the proximal HNFE motif found in mouse and human ASBT promoters was sufficient to enhance the reporter gene activity of an SV40 promoter-CAT construct in presence of SREBP-2. This effect was dramatically strengthened when SREBP-2 and HNF-1a expression vectors were cotransfected together. Second, the double loss of HNFE sequences in mouse and human promoters fully abolished the responsiveness of the ASBT gene to SREBP-2 and SREBP-2/HNF-1a.
How SREBP-2 cooperates with HNF-1a is not yet established. However, an indirect regulation of ASBT gene through SREBP-2 mediated control of HNF-1a expression is unlikely as the HNF-1a gene is not sterol sensitive ( fig 6A) . Likewise, the hypothesis of a bile acid mediated downregulation of the HNF-1a gene 52 was discarded as its mRNA level did not change in 2% cholesterol-fed mice fed ( fig 6B) . A cooperative interaction between HNF-1a and SREBP-2 provides an alternative possibility. Indeed, recent studies have reported that physical protein-protein interactions between SREBP-2 and HNF-4a were responsible for synergic regulation of several of the key genes determining cholesterol metabolism, such as D 8 -isomerase, HMG-CoA synthase, and LDL receptor. 46 Similarly, interaction between SREBP-1 and HNF-4a interferes with the recruitment of the transcriptional coactivator PGC-1 to suppress hepatic gluconeogenic genes. 47 The existence of an interaction between SREBP-2 and HNF1a is conceivable but requires further investigation to fully delineate the mechanism of this cooperation. promoter is SREBP-2 insensitive. Caco-2 cells were co-transfected with hHNF1a
and various amount of SREBP-2 expression vector. CAT activity was normalised to b-galactosidase activity (n = 3). (C) Ileal HNF-1a mRNA levels assessed by real time quantitative polymerase chain reaction in mice fed a 2% cholesterol diet for 14 days or daily force fed simvastatin for four days (n = 4). Values are means with SEM. CAT, chloramphenicol acetyltransferase; HNF, hepatocyte nuclear factor; SREBP, sterol regulatory element binding protein.
Conclusions
Our data provide the first evidence that mouse and human ASBT genes are regulated by cholesterol through an original pathway involving a partnership between SREBP-2, and HNF-1a. This regulation appears to be direct and leads to sustained faecal bile acid output. These new findings also raise the possibility of a coordinated regulation of intestinal and hepatic bile acid transfer following cholesterol feeding, as hepatic bile acid transporters such as NTCP or OATP1 are HNF-1a target genes. 16 
Answer
From question on page 1275 Figure 1 shows a dacron graft reaching several centimetres into the third part of the duodenum far beyond the papilla, surrounded by a sanguineous and fibrinous ulcer of the bowel wall. The patient had a secondary aortoenteric fistula, a late onset complication following reconstructive aortic surgery with an incidence ranging from 1% to 2%. 1 The pathogenesis of secondary aortoenteric fistulas following aortic grafting often involves chronic low grade infection of the graft and perigraft connecting tissue due to suture line failure.
2 After a period of 10-15 years this may eventually lead to penetration into the bowel wall. Mechanical erosion of the bowel wall caused by constant pulsation of the solid aortic graft against the bowel wall is thought to be important. Two types of aortoenteric fistulas have been described. Type 1 is characterised by a direct connection of the aortic lumen at the suture site with the bowel lumen, causing intractable haemorrhage. In type 2 there is communication between the bowel lumen with the perigraft region. Here, bleeding results from erosion of the bowel wall. This was most likely the case in our patient. Localisation in the distal duodenum is also typical (80%) and explains why aortoenteric fistulas are often missed by standard oesophagogastroduodenoscopy. Immediate laparotomy of our patient revealed an infected aortic graft which had penetrated deeply into the duodenal lumen and was greenish as a result of discolouration by bile reflux. The duodenal wall was perforated twice adjacent to the graft. Extensive reconstructive surgery was performed with thrombendarterectomy of the aorta, construction of a right sided aorto-femoral bypass using the femoral vein, construction of an femoro-femoral bypass using the saphenus vein, and removal of the occluded left sided femoropopliteal bypass. Post-haemorrhages necessitated repeated laparotomies with partial resection and oversewing of the duodenum with reconstruction of the aortovenous anastomosis. Recurrent bleeding however led to multiorgan failure and the patient died. Patients with melena are usually referred to the medical department for emergency care. In routine gastrointestinal endoscopy, aortoenteric fistulation is a rare differential diagnosis and may easily be missed, in particular if located in the distal part of the duodenum. With this case we emphasise the need to always consider aortoenteric fistulation as a cause of gastrointestinal haemorrhage in patients with abdominal prosthetic vascular surgery. Once the suspicion is raised an interdisciplinary approach will ensure immediate surgical treatment of the patient. 
